North America Pharmaceutical Isolator Market Size and Competitive Analysis by 2028

The North America pharmaceutical isolator market is expected to grow from US$ 2,532.56 million in 2021 to US$ 4,409.02 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

The US, Canada, and Mexico are economies in North America. Growing investments by pharmaceutical and biotechnology industry is expected to surge the market growth. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for life-threatening conditions. Pharmaceutical isolator systems have been regarded as a key technology in the drug discovery process. Thus, the adoption of pharmaceutical isolators is increasing to ensure contamination-free manufacturing and product handling. The pharmaceutical isolator provides safety to an operator from the exposure of harmful drugs, eliminates the possibilities of cross-contamination, and maintains the standard of drug quality. In the pharmaceutical industry, it is extremely important to maintain immense caution during the product manufacturing process. Different types of isolators are available in the pharmaceutical market that provide an optimum level of sterility in the product manufacturing process. The handling of pharmaceuticals with high potency ingredients, such as hormones and antibiotics. Biologic drugs need a greater level of precautions. Increased investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases, such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the growth of the North America pharmaceutical isolator market.

In case of COVID-19, North America is highly affected specially the US. the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccine against the coronavirus. In May 2020, The U.S. Department of Health and Human Services had collaborated with private players to expand pharmaceutical products in the United States against COVID-19 and further medical emergencies. Phlow Corporation of Richmond, Virginia, leads the collaboration. It has the capacity to produce active pharmaceutical ingredients (APIs) and chemical compounds for critical medicines. It is expected that the production of pharmaceutical products will assist in preventing drug shortages, especially during the COVID-19 pandemic. The collaboration aims to provide the health care systems with complete, sterile, and injectable generic medicines at risk of shortage. The agreement between the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at HHS, is done for four years with US$ 354 million. Thus, the collaboration is expected to show a positive impact on the pharmaceutical isolator market in the coming few years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America pharmaceutical isolator market. The North America pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.

North America Pharmaceutical Isolator Market Segmentation 

North America Pharmaceutical Isolator Market – By Type

• Open Isolators
• Closed Isolators

North America Pharmaceutical Isolator Market – By Pressure

• Positive Pressure
• Negative Pressure

North America Pharmaceutical Isolator Market – By Configuration

• Floor Standing
• Modular
• Compact
• Mobile

North America Pharmaceutical Isolator Market – By Application

• Aseptic
• Sampling & Weighing
• Fluid Dispensing
• Containment    
• Others

North America Pharmaceutical Isolator Market – By End User

• Pharmaceutical and Biotechnology Companies
• Hospitals
• Research and Academic Laboratories
• Other

North America Pharmaceutical Isolator Market, by Country

• US
• Canada   
• Mexico

North America Pharmaceutical Isolator Market -Companies Mentioned

• Azbil Telstar
• Bioquell (Ecolab Solution)
• Comecer
• Fedegari Autoclavi S.p.A. 
• Getinge AB
• Hosokawa Micron Group 
• Nuaire Inc.
• Schematic Engineering Industries

North America Pharmaceutical Isolator Report Scope